Received Apr 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 3G5T3 | RA |
Possible adminstration of Diluent only to the pateint; Possible adminstration of Diluent only to the pateint; This non-serious case was reported by a nurse via sales rep and described the occurrence of inappropriate preparation of medication in a 54-year-old female patient who received Herpes zoster (Shingrix) (batch number 3G5T3, expiry date 20-JUL-2026) for prophylaxis. On 02-FEB-2025, the patient received the 2nd dose of Shingrix (right deltoid). On 02-FEB-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Possible adminstration of Diluent only to the pateint) and inappropriate dose of vaccine administered (Verbatim: Possible adminstration of Diluent only to the pateint). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 14-APR-2025 The nurse reported possible administration of diluent only to the patient which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. This case was linked with US2024158602, reported by same reporter.; Sender's Comments: US-VIIV HEALTHCARE-US2024158602:same reporter